title: Rituximab for tumefactive inflammatory demyelination: a case report.
authors.affiliation: Department of Neurology, Cardiac and Cerebrovascular Hospital of Ningxia Medical University, General Hospital, Yinchuan, Ningxia 750002, China.
authors.forename: Xuewen
authors.initials: X
authors.lastname: Fan
authors.forename: Ali
authors.initials: A
authors.lastname: Mahta
authors.forename: Philip L
authors.initials: PL
authors.lastname: De Jager
authors.forename: Santosh
authors.initials: S
authors.lastname: Kesari
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D003711:Demyelinating Diseases / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D008297:Male; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab